The arithmetic of Shell’s current strategy is striking in its symmetry. On one side sits a freshly completed C$16.5bn acquisition that cements the company’s position in North American natural gas. On the other, a buyback programme that continues to churn through shares with mechanical regularity — most recently absorbing 873,615 of them across the London and Amsterdam exchanges. Together, they sketch a portrait of a supermajor intent on doing two things at once: buying growth where it counts and returning cash where it can.
The Canadian Cornerstone
Shell’s takeover of ARC Resources has now formally closed, wrapping up a transaction that hands ARC shareholders C$8.20 in cash plus 0.40247 Shell shares for each of their holdings. The equity value comes to roughly US$13.9bn, while the enterprise figure — once net debt is factored in — reaches US$16.5bn. Shell funded the deal with US$3.3bn in cash and newly issued shares worth approximately US$10.6bn.
Management’s targets for the Canadian assets are unambiguous: double-digit returns on invested capital, with a contribution to free cash flow expected to materialise from 2027. The acquisition also dovetails with a broader push into the Gulf of America, where subsidiary Shell Offshore Inc. has taken a 30% stake in the Conifer exploration project, developed in tandem with BP. First drilling there is pencilled in for 2027, reinforcing Shell’s status as the region’s largest producer while tilting its portfolio toward lower greenhouse-gas-intensity projects.
Analysts Do the Maths
The market’s arbiters have responded by nudging their models upward. Erste Group Bank raised its 2026 earnings-per-share estimate for Shell from US$11.08 to US$11.18, reaffirming a “Buy” rating in the process. The revision draws support from the second-quarter numbers published on 31 July, when adjusted earnings of US$3.52 per share comfortably beat the US$3.23 consensus — and quarterly revenue of US$94.66bn also came in well ahead of expectations.
That operational momentum helps explain why the stock has been able to absorb the dilution inherent in a share-financed acquisition of this scale. The shares closed the most recent session at €40.02, up 28% since the start of the year and sitting roughly 3.1% below the 52-week high of €41.32. Elevated crude prices — Brent recently changed hands near US$95 a barrel — have provided a supportive tailwind across the sector.
The Other Track: Divestment and Buybacks
While the Canadian deal strengthens Shell’s upstream hand, the company continues to prune the portfolio’s less profitable branches. Reports circulating in capital markets suggest Shell is exploring a sale of its US chemicals assets at a valuation of around US$8bn, with ExxonMobil and private equity firm Apollo among the interested parties. The message embedded in that potential exit is consistent with the ARC acquisition: concentrate capital where returns are demonstrably strong, and release it where they are not.
Should investors sell immediately? Or is it worth buying Shell?
The Aphrodite offshore gas project off Trinidad and Tobago has meanwhile been shelved after commercial negotiations with the country’s state gas company broke down — another sign that Shell would rather walk away than tie up money in marginal ventures.
None of this has interrupted the cadence of the share repurchase programme, which Goldman Sachs is executing and which is slated to run until 23 October 2026. The latest tranche of buybacks came just this week, continuing a rhythm that has become a defining feature of Shell’s shareholder proposition.
A Coherent Whole
What emerges is a strategy that is less a collection of discrete moves than a coherent allocation of capital across a spectrum of options. The ARC acquisition addresses the need for scale in stable, low-risk gas production. The chemicals divestment addresses the drag of lower-margin operations. The buybacks address the perennial question of what to do with surplus cash when organic opportunities are scarce.
The market’s verdict, for now, is cautiously positive. The stock’s year-to-date gain of 28% suggests investors see the logic — even if the shares remain a few percentage points shy of their peak. Whether the Canadian integration delivers the promised double-digit returns, and whether the chemicals sale completes on terms close to the mooted US$8bn, will determine whether the current optimism proves durable or merely reflects a favourable oil-price environment. For a company executing on multiple fronts simultaneously, the near-term catalysts are plentiful — and the margin for error correspondingly thin.
Ad
Shell Stock: Buy or Sell?! New Shell Analysis from September 3 delivers the answer:
The latest Shell figures speak for themselves: Urgent action needed for Shell investors. Is it worth buying or should you sell? Find out what to do now in the current free analysis from September 3.
Shell: Buy or sell? Read more here...
